The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Nov. 22, 2022
Filed:
May. 20, 2020
Applicant:
Intra-cellular Therapies, Inc., New York, NY (US);
Inventor:
Lawrence P. Wennogle, Hillsborough, NJ (US);
Assignee:
INTRA-CELLULAR THERAPIES, INC., New York, NY (US);
Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61K 31/519 (2006.01); A61P 25/16 (2006.01); A61P 25/14 (2006.01); A61P 25/28 (2006.01); A61P 25/02 (2006.01); A61K 31/527 (2006.01); A61K 31/53 (2006.01); A61K 31/517 (2006.01); G01N 33/84 (2006.01);
U.S. Cl.
CPC ...
A61K 31/519 (2013.01); A61K 31/517 (2013.01); A61K 31/527 (2013.01); A61K 31/53 (2013.01); A61P 25/02 (2018.01); A61P 25/14 (2018.01); A61P 25/16 (2018.01); A61P 25/28 (2018.01); G01N 33/84 (2013.01); G01N 2333/4727 (2013.01); G01N 2800/28 (2013.01);
Abstract
The subject matter generally relates to methods of treatment and/or prophylaxis of CNS diseases, disorders, and/or injuries. In one aspect, the subject matter relates to inhibitors of phosphodiesterase 1 (PDE1) as neuroprotective agents and/or neural regenerative agents. In a further aspect, the subject matter relates to individuals that are at risk for the development of CNS disease or disorder.